UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

_____________

 

Form 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May14, 2012

 

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in charter)

 

                   Florida      0-11102         59-1564329
(State or Other Jurisdiction of Incorporation) (Commission File Number) I.R.S. Employer Identification No.)

 

4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive offices) (Zip Code)

  

(954) 587-6280

Registrant’s telephone number, including area code:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On May 9, 2012, Ocean Bio-Chem, Inc. (the “Company”) granted stock awards to each of its named executive officers (as listed in the proxy statement for its 2012 Annual Meeting of Shareholders), as set forth in the following table:

 

 Name and Position

  

Number of Shares
Underlying Stock Award

     

Peter G. Dornau

Chairman of the Board, President and Chief Executive Officer

 

  

 

15,000

Gregor M. Dornau

Vice President - Sales & Marketing

 

  

 

15,000

Jeffrey S. Barocas

Vice President-Finance and Chief Financial Officer

 

  

 

16,000

William W. Dudman

Vice President – Operations and Secretary

 

  

 

15,000

 

All stock awards vested immediately upon grant. The stock awards were issued under the Ocean Bio-Chem, Inc. Omnibus Equity Compensation Plan

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

May 15, 2012 

  Ocean Bio-Chem, Inc.
   
  By:  /s/ Jeffrey S. Barocas
   

Jeffrey S. Barocas

Vice President-Finance and

Chief Financial Officer

 

3